Jie Jin
7 Papers
Jie Jin is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has co-authored 6 publications.
Chat about Author
Papers
Proteomic Portrait of Human Lymphoma Reveals Protein Molecular Fingerprint of Disease Specific Subtypes and Progression
Xin Ku,Jinghan Wang,Haikuo Li,Chen Meng,Fang Yu,Wenjuan Yu,Zhongqi Li,Ziqi Zhou,Can Zhang,Ying Hua,Wei Yan,Jie Jin +11 more
TL;DR: In this article , a comprehensive proteomic study aimed to establish a proteomic landscape of patients with various lymphatic disorders and identify proteomic variations associated with different disease subgroups was conducted.
11
Hsa_circ_0007099 and PIP4K2A coexpressed in diffuse large B-cell lymphoma with clinical significance
Jinghan Wang,Ku Xin,Qiu-ling Ma,Haikuo Li,Sujuan Huang,Liping Mao,Fang Yu,Jie Jin,Wei Yan +8 more
- 01 Jul 2023
3
Salvage treatment in IDH1 mutated acute lymphoblastic leukemia with venetoclax plus methotrexate and pegaspargase: A case report
TL;DR: This work successfully rescued a relapsed ALL case with IDH1mutation by VEN plus methotrexate and pegaspargase based on their antimetabolic pathways, and reported a complete response after one cycle of the VDCLP regimen.
2
Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group.
Hui-Sheng Ai,Nelson J. Chao,David A. Rizzieri,Xiaojun Huang,Thomas R. Spitzer,Jianxiang Wang,Mei Guo,Armand Keating,Elizabeth F. Krakow,Didier Blaise,Jun Ma,Depei Wu,John L. Reagan,Usama Gergis,Rafael F. Duarte,Preety Chaudhary,Kai-Xun Hu,Chang-Lin Yu,Qi-Yun Sun,Ephraim J. Fuchs,B Cai,Ya-Jing Huang,Jia Qiao,David Gottlieb,Kirk R. Schultz,Mingyao Liu,Xiequn Chen,Wenming Chen,Jianmin Wang,Xiao-Hui Zhang,Jianyong Li,H. Huang,Zimin Sun,Fei Li,Linhua Yang,Lian-sheng Zhang,Lijuan Li,Kaiyan Liu,Jie Jin,Qifa Liu,Daihong Liu,Chun Ji Gao,Chuanbo Fan,Li Wei,Xi Zhang,Liangding Hu,Weijing Zhang,Yuyang Tian,Weidong Han,Jun-Ming Zhu,Zhijian Xiao,Daobin Zhou,Bolong Zhang,Yongqing Zhang,Xiaoxiong Wu,Xu-Liang Shen,Xuzhang Lu,Xinrong Zhan,Xiuli Sun,Yi Xiao,Jing Wang,Xiaoding Shi,Bo Zheng,Jie Chen,Banghe Ding,Zhao Wang,Fang Zhou,Meixiang Zhang,Yizhuo Zhang,Jie Sun,Bing Xia,Baoan Chen,Liang-Min Ma +72 more
TL;DR: In this paper , the International Microtransplant Interest Group provides recommendations and considerations for microtransplant in the treatment of elderly acute myeloid leukemia (EAML), and four major issues related to MST for treating EAML were addressed: therapeutic principle of MST, candidates for MST (1), induction chemotherapy regimens (3), and post-remission therapy based on MST.
2
Re: CARTIFAN-1: Concerning fatal adverse events with global use of chimeric antigen receptor-T-cell therapy in multiple myeloma.
TL;DR: CARTIFAN-1 reported safety and efficacy data on the use of ciltacabtagene autoleucel (cilta-cel), a B-cell maturation antigen-targeting CAR-T therapy, in relapsed/refractory multiple myeloma (RRMM) as discussed by the authors .